IMUNON to Hold 2025 Financial Results and Business Update Conference Call on Tuesday, March 31, 2026
IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, today announced that the Company will host a conference call at 11:00 a.m.
Chagee Holdings Limited (NASDAQ: CHA) (“Chagee” or the “Company”), a leading premium tea drinks brand serving healthy and ...
LM Funding America, Inc. (NASDAQ: LMFA) ('LM Funding” or the 'Company”), a Bitcoin treasury and mining company, today announced that it has scheduled its fourth quarter and full year 2025 earnings ...
Achieve also Announces Partnership with U.S.-based Adare Pharma Solutions for Cytisinicline Manufacturing Conference Call ...
AI technology company Anthropic is currently engaged in a hostile dispute with the U.S. Defense Department, and the fallout ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results